ClinicalTrials.gg
RecruitingNCT07854015Updated Nov 18, 2026

LI4 Acupuncture for Pain During Intrauterine Device Insertion

An interventional study of LI4 Acupuncture and Sham Acupuncture in Pain Associated With Intrauterine Device Insertion, sponsored by Nigde Omer Halisdemir University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Nigde Omer Halisdemir University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 18, 2026Now RecruitingSite recruiting status changed+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
150
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Pain, Procedural with a site in Turkey — 14 open to participants now, 14 under way, none of them phase 3. Pain, Procedural · Turkey.

Planned enrollment
12th of 79
150 · median 100
Started
2026
with 19 others
No phase
77 of 81
13 open now
Primary completion
2027-07
later than 13 of 13 live
Registered
73rd of 81
by date

Among the 81 studies in Pain, Procedural with a site in Turkey, this one is the 12th largest by planned enrollment of the 79 interventional ones that give a count, is one of 20 that started in 2026, is one of 77 with no phase, reaches primary completion later than 13 of the 13 other live ones, and was the 73rd registered.

Pain, Procedural

246 studies on the registry are indexed under Pain, Procedural; 66 are open to participants now.

Browse Pain, Procedural studies →

Open to participants now

14 of the 81 studies in Pain, Procedural with a site in Turkey are open now. Recruiting first, the newest first:

8 more — sign in →

All 14 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 30 Pain, Procedural studies recruiting now, 13 (43%) set no upper age limit and 15 (50%) stop at 75 or younger; 14 take children under 18; 6 take healthy volunteers.

This study: 18 Years to 50 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Pain, Procedural with a site in Turkey, or all of them as a file.
02

Study summary

This study will evaluate whether acupuncture can reduce pain during intrauterine device (IUD) insertion. Women undergoing IUD insertion will be randomly assigned to receive either real acupuncture at the LI4 point on both hands or a sham acupuncture procedure that does not penetrate the skin. Both interventions will be applied for 15 minutes before IUD insertion. Participants will not know which treatment they receive. The clinician performing the IUD insertion and the researcher assessing the outcomes will also be unaware of the treatment assignment. Pain will be measured at different stages of the IUD insertion procedure and shortly after the procedure. The main outcome will be the highest pain score reported during IUD insertion. The study will also assess procedure tolerance, patient satisfaction, need for additional pain medication, and adverse events.

Read the detailed description

Pain during intrauterine device (IUD) insertion may affect procedure tolerance and patients' experience with this highly effective contraceptive method. Although several pharmacological approaches have been investigated for pain control during IUD insertion, their effectiveness has been inconsistent, and there is no universally accepted analgesic approach.

LI4 (Hegu) is an acupuncture point commonly used for analgesia. In a previous randomized controlled trial conducted by the investigators, bilateral LI4 acupuncture before IUD insertion was associated with lower post-procedural pain scores compared with no intervention. However, the absence of a sham control in that study did not allow specific effects of acupuncture to be distinguished from placebo and other nonspecific effects.

The present randomized, sham-controlled trial is therefore designed to evaluate the analgesic effect of bilateral LI4 acupuncture using a non-penetrating Park sham procedure as the comparator. The primary focus is pain experienced during the IUD insertion procedure. The sham-controlled and masked design is intended to reduce expectancy and assessment bias and provide a more rigorous estimate of the effect of LI4 acupuncture on procedure-related pain.

The IUD insertion procedure will be standardized across both study groups. No routine analgesic premedication will be administered before the procedure. IUD insertion will be performed according to the same standardized clinical protocol in all participants, including speculum placement, visualization of the cervix, tenaculum application, measurement of the uterine cavity, and IUD insertion. No analgesic medication will be routinely administered during the procedure. After completion of the scheduled pain assessments, an NSAID may be administered as rescue analgesia if clinically required, and its use will be recorded. Apart from the assigned acupuncture or sham acupuncture intervention, procedural management will be identical between the two groups.

03

Conditions studied

  • Pain Associated With Intrauterine Device Insertion

Browse trials for

Keywords

  • Acupuncture
  • LI4
  • Hegu
  • Intrauterine Device
  • IUD Insertion
  • Procedural Pain
  • Pain Management
  • Sham Acupuncture
  • Park Sham Device
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18-50 years
  • Scheduled to undergo copper intrauterine device (IUD) insertion for
  • Able to communicate in Turkish
  • Able to understand and use the Visual Analog Scale (VAS) for pain assessment
  • Able and willing to provide written

Exclusion criteria

Exclusion Criteria:

  • Confirmed or suspected pregnancy
  • Active pelvic infection
  • Unexplained abnormal uterine bleeding
  • Any to IUD insertion
  • Use of opioid analgesic or sedative medication within the preceding 24 hours
  • Known allergy or to acupuncture needle materials
  • Needle phobia
  • Infection, wound, or other significant skin lesion at or near the acupuncture site
  • Serious psychiatric disorder or cognitive impairment that may interfere with pain assessment or study participation
  • Neurological disease or sequelae that may interfere with pain perception or pain assessment
  • Requirement for an emergency procedure
  • Previous participation in this study
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Hypersensitivity

An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
150 participants (estimated)

Study arms

  • Experimental
    LI4 Acupuncture

    Participants assigned to this arm will receive bilateral acupuncture at the LI4 (Hegu) point 15 minutes before IUD insertion. Sterile 0.25 × 25 mm acupuncture needles will be inserted to a depth of approximately 1.5-2 cm. Manual stimulation will be applied to elicit de qi. The needles will remain in place for 15 minutes and will be removed before the IUD insertion procedure.

    Procedure: LI4 Acupuncture

  • Sham comparator
    Sham Acupuncture

    Participants assigned to this arm will receive bilateral sham acupuncture at the LI4 (Hegu) point using Park-type non-penetrating sham needles 15 minutes before IUD insertion. The sham needles will not penetrate the skin, and no de qi or manual stimulation will be elicited. The sham procedure will last 15 minutes and will be completed before the IUD insertion procedure, with the duration of treatment and participant-practitioner interaction standardized to match the LI4 acupuncture arm.

    Procedure: Sham Acupuncture

Interventions

  • ProcedureLI4 Acupuncture

    Bilateral acupuncture will be performed at the LI4 (Hegu) point 15 minutes before IUD insertion using sterile 0.25 × 25 mm acupuncture needles. Needles will be inserted to a depth of approximately 1.5-2 cm, and manual stimulation will be applied to elicit de qi. The needles will remain in place for 15 minutes and will then be removed before the IUD insertion procedure.

  • ProcedureSham Acupuncture

    Bilateral sham acupuncture will be performed at the LI4 (Hegu) point 15 minutes before IUD insertion using Park-type non-penetrating sham needles. The sham needles will not penetrate the skin, and no de qi or manual stimulation will be elicited. The sham procedure will last 15 minutes and will be completed before IUD insertion. Treatment duration and participant-practitioner interaction will be standardized to match the LI4 acupuncture intervention.

06

What researchers measure

Primary outcomes

  1. Maximum Procedure-Related Pain During IUD Insertion

    Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), at three predefined procedural stages: tenaculum application, passage through the uterine cavity, and fundal placement of the IUD. For each participant, the highest VAS score recorded across these three stages will be defined as the maximum procedure-related pain score. Higher scores indicate greater pain.

    Time frame: During the IUD insertion procedure

Secondary outcomes

  1. Pain During Tenaculum Application

    Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), during tenaculum application. Higher scores indicate greater pain.

    Time frame: During tenaculum application

  2. Pain During Passage Through the Uterine Cavity

    Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), during passage through the uterine cavity. Higher scores indicate greater pain.

    Time frame: During passage through the uterine cavity

  3. Pain During Fundal Placement of the IUD

    Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain), during fundal placement of the IUD. Higher scores indicate greater pain.

    Time frame: During fundal placement of the IUD

  4. Pain at 3 Minutes After IUD Insertion

    Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain.

    Time frame: 3 minutes after completion of IUD insertion

  5. Pain at 10 Minutes After IUD Insertion

    Pain will be assessed using a 10-cm Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain.

    Time frame: 10 minutes after completion of IUD insertion

  6. Occurrence of Vasovagal Reaction

    Occurrence of a clinically observed vasovagal reaction associated with the IUD insertion procedure will be recorded as yes or no.

    Time frame: During IUD insertion and through 10 minutes after the procedure

  7. Use of Rescue Analgesia

    The need for rescue analgesic medication related to pain during or immediately after the IUD insertion procedure will be recorded as yes or no.

    Time frame: During IUD insertion and through 10 minutes after the procedure

  8. Procedure Tolerance

    Participants will rate their overall tolerance of the IUD insertion procedure using an 11-point numerical rating scale ranging from 0 (completely intolerable) to 10 (completely tolerable). Higher scores indicate better procedure tolerance.

    Time frame: 10 minutes after completion of IUD insertion

  9. Patient Satisfaction

    Participants will rate their overall satisfaction with the IUD insertion experience using an 11-point numerical rating scale ranging from 0 (not at all satisfied) to 10 (completely satisfied). Higher scores indicate greater satisfaction.

    Time frame: 10 minutes after completion of IUD insertion

  10. Willingness to Choose the Same Method Again

    Participants will be asked whether they would choose the same contraceptive method again based on their current IUD insertion experience. Responses will be recorded as yes or no.

    Time frame: 10 minutes after completion of IUD insertion

  11. Pain Compared With Preprocedural Expectation

    Participants will be asked to compare the pain experienced during IUD insertion with the pain they expected before the procedure. Responses will be categorized as less painful than expected, approximately as painful as expected, or more painful than expected.

    Time frame: 10 minutes after completion of IUD insertion

Other outcomes

  1. Acupuncture-Related Adverse Events

    Adverse events potentially related to the acupuncture or sham acupuncture intervention will be assessed, including local pain, minor bleeding, hematoma, and dizziness. The occurrence of one or more of these events will be recorded for each participant.

    Time frame: From initiation of the acupuncture or sham procedure through 10 minutes after IUD insertion

  2. Participant Blinding Assessment

    Participants will be asked to indicate which intervention they believe they received. Response options will be: real acupuncture, sham acupuncture, or do not know. The distribution of responses will be compared between randomized groups to assess the success of participant blinding.

    Time frame: 10 minutes after completion of IUD insertion, after completion of the other outcome assessments

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual participant data underlying the results reported in the published article may be shared upon reasonable request to the corresponding author, following publication of the study results and subject to approval of the proposed use and applicable ethical and institutional requirements.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Beginning 6 months after publication of the study results and available for 5 years thereafter.

Access criteria: Deidentified individual participant data underlying the results reported in the published article, together with the study protocol, statistical analysis plan, and analytic code, will be available to qualified researchers upon reasonable request to the corresponding author. Requests should include a scientifically sound research proposal and a description of the intended use of the data. Access will be subject to approval by the study investigators and applicable ethical and institutional requirements. Data will be provided through a secure data-sharing method following approval.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2026 (actual). Primary completion is estimated for Jul 2027, 7 months after the start.

Of 145 non-industry interventional studies with no phase under Pain, Procedural, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 7 months is close to that.

Counting every sponsor, half of 145 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: start Oct 2026 → Nov 2026, primary completion May 2027 → Jul 2027 and completion May 2027 → Jul 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 27, 2026
First posted
Oct 2, 2026
StartActual
Nov 10, 2026was Oct 2026
Primary completionEst.
Jul 1, 2027was May 2027
CompletionEst.
Jul 1, 2027was May 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 18, 2026
Sites
Niğde Ömer Halisdemir University Hospital is now Recruiting
Nov 18, 2026
Start date
Oct 15, 2026→Nov 10, 2026 (actual)
Nov 18, 2026
Primary completion
May 1, 2027→Jul 1, 2027
Nov 18, 2026
Study completion
May 1, 2027→Jul 1, 2027
Nov 18, 2026
Registered
First appeared on the registry
Oct 2, 2026
Show all 2 updates
  1. Nov 18, 2026
    Not yet recruiting→Recruiting
    Niğde Ömer Halisdemir University Hospital is now Recruiting
    Start date Oct 15, 2026→Nov 10, 2026 (now actual)
    Primary completion May 1, 2027→Jul 1, 2027
    Study completion May 1, 2027→Jul 1, 2027
  2. Oct 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07854015
Lead sponsor
Nigde Omer Halisdemir University
Responsible party
Pınar Erdoğan (Assoc. Prof., Nigde Omer Halisdemir University) — Principal investigator
First posted
Oct 2, 2026
Start date
Nov 10, 2026
Primary completion
Jul 1, 2027 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Pınar Erdoğan, Assoc. Prof.
Contact
drpinarerdogan@gmail.com
905233646954

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion